| Tipiracil HCl/Trifluridine |
Tablet |
II (Paddle) |
50 |
0.1 N HCl |
900 |
5, 10, 15, 20 and 30 |
2017/11/02 |
| Tipranavir |
Capsule |
II (Paddle) |
50 |
0.05 M phosphate buffer pH 6.8 |
900 |
15, 30, 45 and 60 |
2007/12/03 |
| Tivozanib HCl |
Capsule |
II (Paddle with sinker) |
50 |
Tier I: 0.1 mM HCI with 0.5% (w/v) sodium dodecyl sulfate (SDS) (900 mL); Tier II: 0.1 mM HCI with pepsin (as per USP) (750 mL) for the first 10 minutes, followed by addition of 0.1 mM HCI with SDS (3% w/v) (150 mL) for the remainder of the dissolution |
900 |
5, 10, 15, 20 and 30 |
2023/02/09 |
| Tizanidine HCl |
Capsule |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Tizanidine HCl |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Tofacitinib Citrate |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Tofacitinib Citrate |
Tablet (Extended Release) |
II (Paddle) with option to use a sinker |
50 |
Phosphate Buffer, pH 6.8 |
900 |
1, 1.5, 2, 2.5, 3, 4, 6 and 8 hours |
2016/07/28 |
| Tolcapone |
Tablet |
|
|
Refer to USP |
|
|
2013/05/09 |
| Tolmetin Sodium |
Tablet |
|
|
Refer to USP |
|
|
2026/03/25 |
| Tolmetin Sodium |
Capsule |
|
|
Refer to USP |
|
|
2026/03/25 |
| Tolterodine Tartrate |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Tolterodine Tartrate |
Capsule (Extended Release) |
I (Basket) |
100 |
Phosphate buffer (pH 6.8) |
900 |
1, 3, 7 hours |
2007/06/18 |
| Tolvaptan |
Tablet |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Topiramate |
Capsule (Sprinkle) |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Topiramate |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Topiramate [25, 50, 100, 150 mg and 200 mg] |
Capsule (Extended Release) |
I (Basket) |
100 |
50 mM Tris buffer, pH 7.2 |
900 |
0.5, 1, 2, 4, 6 and 8 hours |
2015/06/25 |
| Topiramate [25, 50, 100 and 200 mg] |
Capsule (Extended Release) |
II (Paddle) |
50 |
0.05 M Phosphate Buffer, pH 7.5 |
750 |
1, 2, 3, 4, 6 and 8 hours |
2014/08/14 |
| Topotecan HCl |
Capsule |
II (Paddle) |
50 |
Acetate Buffer with 0.15% SDS, pH 4.5 |
500 |
5, 10, 20, 30 and 45 |
2009/04/27 |
| Toremifene Citrate |
Tablet |
II (Paddle) |
50 |
0.02 N HCl |
1000 |
10, 20, 30 and 45 |
2004/02/20 |
| Torsemide [40 mg] |
Tablet |
II (Paddle) |
75 |
0.1 N HCl |
900 |
1, 2, 3, 4, 6, 8, 10 and 12 hours |
2022/07/07 |